EcoR1 Capital’s Eloxx Pharmaceuticals ELOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.12M Hold
400,000
– – 0.27% 29
2026
Q2
$5.55M Buy
+400,000
New +$5.1M 0.27% 28

Other funds holding ELOX

EcoR1 Capital's ELOX Position: Q3 2026 in Review

EcoR1 Capital held its Eloxx Pharmaceuticals (ELOX) position steady in Q3 2026 at 400,000 shares worth $6.12M. The position accounts for 0.27% of the portfolio, ranked #29.

EcoR1 Capital first reported a position in ELOX in Q2 2026 and has held it in 2 quarters since. 20 funds tracked by Wall St. Rank hold ELOX as of Q3 2026.

  • EcoR1 Capital held 400,000 shares of Eloxx Pharmaceuticals worth $6.12M as of Q3 2026.
  • EcoR1 Capital left its Eloxx Pharmaceuticals share count unchanged in Q3 2026.
  • Eloxx Pharmaceuticals made up 0.27% of EcoR1 Capital's portfolio in Q3 2026, its #29 holding.
  • EcoR1 Capital first reported a position in Eloxx Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 20 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals as of Q3 2026.

Based on EcoR1 Capital's 13F filing for Q3 2026, filed 16 Nov 2026.